Study confirms role of brain’s support cells in Huntington’s, points to new therapies
New research gives scientists a clearer picture of what is happening in the brains of people with Huntington’s disease and […]
» Read moreTo help patients with muscle disorders, scientists at The University of Texas Health Science Center at Houston (UTHealth) have engineered […] Like Zika, infection with Rift Valley fever virus can go unnoticed during pregnancy, all the while doing irreparable—often lethal—harm to […] The human brain is rich in lipids. Investigators studying Parkinson’s disease (PD) have become increasingly interested in lipids since both […] Many factors affect cancer treatment outcome, such as the size and location of the tumor, availability of effective treatments, and […] After a serious injury, the leading cause of death is loss of blood. Major trauma victims who receive transfusions of […] The 28-day tea-tox: Can trendy new herbal teas and powders really help you slim? It is a beguiling prospect: a […] Cutaneous leishmaniasis (CL) is a parasitic infection caused by Leishmania parasite. CL cases have increased dramatically in Syria and neighboring […] In 2017, the American College of Cardiology and the American Heart Association released new blood pressure guidelines, lowering hypertension threshold […] FRIDAY, Nov. 16, 2018 — As part of a new effort to cut the use of dogs in drug trials, […]
Stem cell researchers develop promising technique to generate new muscle cells in lab
New study uncovers why Rift Valley fever is catastrophic to developing fetuses
New Parkinson’s disease drug target revealed through study of fatty acids
New study reveals how cancer manipulates our immune system to become harder to treat
Transfusions with older blood linked to adverse events, death, new study finds
Can trendy new herbal teas and powders really help you slim?
Advancement in drug therapies may provide new treatment for Cutaneous leishmaniasis
New blood pressure guideline could prevent 3 million cardiovascular events over 10 years
Under New Plan, FDA Hopes to Cut Use of Dogs in Veterinary Drug Trials
